Association of Differing Qatari Genotypes with Vitamin D Metabolites

Objective. Genetic studies have identified four Qatari genotypes: Q1 Arab, Bedouin; Q2 Asian/Persian; Q3 African; and a fourth admixed group not fitting into the previous 3 groups. This study was undertaken to determine if there was an increased risk of deficiency of vitamin D and its metabolites as...

Full description

Saved in:
Bibliographic Details
Main Authors: Youssra Dakroury, Alexandra E. Butler, Soha R. Dargham, Aishah Latif, Amal Robay, Ronald G. Crystal, Stephen L. Atkin
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2020/7831590
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832568640972521472
author Youssra Dakroury
Alexandra E. Butler
Soha R. Dargham
Aishah Latif
Amal Robay
Ronald G. Crystal
Stephen L. Atkin
author_facet Youssra Dakroury
Alexandra E. Butler
Soha R. Dargham
Aishah Latif
Amal Robay
Ronald G. Crystal
Stephen L. Atkin
author_sort Youssra Dakroury
collection DOAJ
description Objective. Genetic studies have identified four Qatari genotypes: Q1 Arab, Bedouin; Q2 Asian/Persian; Q3 African; and a fourth admixed group not fitting into the previous 3 groups. This study was undertaken to determine if there was an increased risk of deficiency of vitamin D and its metabolites associated with differing genotypes, perhaps due to genetic differences in skin pigmentation. Methods. 398 Qatari subjects (220 type 2 diabetes and 178 controls) had their genotype determined by Affymetrix 500 k SNP arrays. Total values of 1,25-dihydroxyvitamin D (1,25(OH)2D), 25-hydroxyvitamin D (25(OH)D), 24,25-dihydroxyvitamin D (24,25(OH)2D), and 25-hydroxy-3epi-vitamin D (3epi-25(OH)D) concentrations were measured by the LC-MS/MS analysis. Results. The distribution was as follows: 164 (41.2%) genotyped Q1, 149 (37.4%) genotyped Q2, 31 (7.8%) genotyped Q3, and 54 (13.6%) genotyped “admixed.” Median levels of 25(OH)D and 3epi-25(OH)D did not differ across Q1, Q2, Q3, and “admixed” genotypes, respectively. 1,25(OH)2D levels were lower (p<0.04) between Q2 and the admixed groups, and 24,25(OH)2D levels were lower (p<0.05) between Q1 and the admixed groups. Vitamin D metabolite levels were lower in females for 25(OH)D, 1,25(OH)2D (p<0.001), and 24,25(OH)2D (p<0.006), but 3epi-25(OH)D did not differ (p<0.26). Diabetes prevalence was not different between genotypes. Total 1,25(OH)2D (p<0.001), total 24,25(OH)2D (p<0.001), and total 3epi-25(OH)D (p<0.005) were all significantly lower in diabetes patients compared to controls whilst the total 25(OH)D was higher in diabetes than controls (p<0.001). Conclusion. Whilst 25(OH)D levels did not differ between genotype groups, 1,25(OH)2D and 24,25(OH)2D were lower in the admixed group, suggesting that there are genetic differences in vitamin D metabolism that may be of importance in a population that may allow a more targeted approach to vitamin D replacement. This may be of specific importance in vitamin D replacement strategies with the Q2 genotype requiring less, and the other genotypes requiring more to increase 1,25(OH)2D. Whilst overall the group was vitamin D deficient, total 25(OH)D was higher in diabetes, but 1,25(OH)2D, 24,25(OH)2D, and 3epi-25(OH)D were lower in diabetes that did not affect the relationship to genotype.
format Article
id doaj-art-60856358be0c40e3928b38c2f904f314
institution Kabale University
issn 1687-8337
1687-8345
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-60856358be0c40e3928b38c2f904f3142025-02-03T00:58:41ZengWileyInternational Journal of Endocrinology1687-83371687-83452020-01-01202010.1155/2020/78315907831590Association of Differing Qatari Genotypes with Vitamin D MetabolitesYoussra Dakroury0Alexandra E. Butler1Soha R. Dargham2Aishah Latif3Amal Robay4Ronald G. Crystal5Stephen L. Atkin6Weill Cornell Medicine-Qatar, P.O. Box 24144, Doha, QatarDiabetes Research Center (DRC), Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Doha, QatarWeill Cornell Medicine-Qatar, P.O. Box 24144, Doha, QatarAntidoping Laboratory, Doha, QatarWeill Cornell Medicine-Qatar, P.O. Box 24144, Doha, QatarDepartment of Genetic Medicine, Weill Cornell Medicine, New York, USAWeill Cornell Medicine-Qatar, P.O. Box 24144, Doha, QatarObjective. Genetic studies have identified four Qatari genotypes: Q1 Arab, Bedouin; Q2 Asian/Persian; Q3 African; and a fourth admixed group not fitting into the previous 3 groups. This study was undertaken to determine if there was an increased risk of deficiency of vitamin D and its metabolites associated with differing genotypes, perhaps due to genetic differences in skin pigmentation. Methods. 398 Qatari subjects (220 type 2 diabetes and 178 controls) had their genotype determined by Affymetrix 500 k SNP arrays. Total values of 1,25-dihydroxyvitamin D (1,25(OH)2D), 25-hydroxyvitamin D (25(OH)D), 24,25-dihydroxyvitamin D (24,25(OH)2D), and 25-hydroxy-3epi-vitamin D (3epi-25(OH)D) concentrations were measured by the LC-MS/MS analysis. Results. The distribution was as follows: 164 (41.2%) genotyped Q1, 149 (37.4%) genotyped Q2, 31 (7.8%) genotyped Q3, and 54 (13.6%) genotyped “admixed.” Median levels of 25(OH)D and 3epi-25(OH)D did not differ across Q1, Q2, Q3, and “admixed” genotypes, respectively. 1,25(OH)2D levels were lower (p<0.04) between Q2 and the admixed groups, and 24,25(OH)2D levels were lower (p<0.05) between Q1 and the admixed groups. Vitamin D metabolite levels were lower in females for 25(OH)D, 1,25(OH)2D (p<0.001), and 24,25(OH)2D (p<0.006), but 3epi-25(OH)D did not differ (p<0.26). Diabetes prevalence was not different between genotypes. Total 1,25(OH)2D (p<0.001), total 24,25(OH)2D (p<0.001), and total 3epi-25(OH)D (p<0.005) were all significantly lower in diabetes patients compared to controls whilst the total 25(OH)D was higher in diabetes than controls (p<0.001). Conclusion. Whilst 25(OH)D levels did not differ between genotype groups, 1,25(OH)2D and 24,25(OH)2D were lower in the admixed group, suggesting that there are genetic differences in vitamin D metabolism that may be of importance in a population that may allow a more targeted approach to vitamin D replacement. This may be of specific importance in vitamin D replacement strategies with the Q2 genotype requiring less, and the other genotypes requiring more to increase 1,25(OH)2D. Whilst overall the group was vitamin D deficient, total 25(OH)D was higher in diabetes, but 1,25(OH)2D, 24,25(OH)2D, and 3epi-25(OH)D were lower in diabetes that did not affect the relationship to genotype.http://dx.doi.org/10.1155/2020/7831590
spellingShingle Youssra Dakroury
Alexandra E. Butler
Soha R. Dargham
Aishah Latif
Amal Robay
Ronald G. Crystal
Stephen L. Atkin
Association of Differing Qatari Genotypes with Vitamin D Metabolites
International Journal of Endocrinology
title Association of Differing Qatari Genotypes with Vitamin D Metabolites
title_full Association of Differing Qatari Genotypes with Vitamin D Metabolites
title_fullStr Association of Differing Qatari Genotypes with Vitamin D Metabolites
title_full_unstemmed Association of Differing Qatari Genotypes with Vitamin D Metabolites
title_short Association of Differing Qatari Genotypes with Vitamin D Metabolites
title_sort association of differing qatari genotypes with vitamin d metabolites
url http://dx.doi.org/10.1155/2020/7831590
work_keys_str_mv AT youssradakroury associationofdifferingqatarigenotypeswithvitamindmetabolites
AT alexandraebutler associationofdifferingqatarigenotypeswithvitamindmetabolites
AT sohardargham associationofdifferingqatarigenotypeswithvitamindmetabolites
AT aishahlatif associationofdifferingqatarigenotypeswithvitamindmetabolites
AT amalrobay associationofdifferingqatarigenotypeswithvitamindmetabolites
AT ronaldgcrystal associationofdifferingqatarigenotypeswithvitamindmetabolites
AT stephenlatkin associationofdifferingqatarigenotypeswithvitamindmetabolites